Lilly and subsidiary Point Biopharma accused of patent infringement of cancer drugs
At issue is whether a drug developed by Point Biopharma, based in Indianapolis, infringed on a patent issued in 2020 and assigned to Purdue Research Foundation.
Patent
-
Purdue wins $32.5M in patent-infringement lawsuit
A jury found STMicroelectronics infringed on a Purdue patent by making and selling products for a technology related to semiconductor devices used in high-voltage power applications.
Read More -
Corteva sues startup rival Inari for patent infringement
The lawsuit seeks to prevent Inari “from continuing its brazen efforts to steal Corteva’s groundbreaking, patent-protected work,” according to the complaint.
Read More -
Purdue University files patent-infringement suit against Google
The dispute concerns technology that the university says was developed and patented by a team of professors and graduate students to address “power bugs” in mobile phone apps.
Read More
Articles
FullBeauty Brands faces patent litigation over swimsuit styles
FullBeauty Brands, which has its mail-order business in Indianapolis, is facing a lawsuit from a competitor who alleges several of FullBeauty’s swimsuits infringe on the competitor’s patented designs.
Apple seeks way to get two of its top watches back on shelves during patent dispute
The company cut off sales right before the Christmas holiday and, in a motion filed Tuesday, Apple said it would suffer “irreparable harm” if previous court orders remain.
Judge overturns $176.5M jury verdict against Lilly in patent infringement suit
The decision represents a rare case of a judge overturning a jury verdict and is a major win for Lilly, which argued strenuously that its Emgality drug is substantially different than Anjovy, a drug sold by competitor Teva Pharmaceuticals.
Lilly’s osteoporosis drug faces generic challenge from Indian drugmaker
Eli Lilly’s blockbuster drug for osteoporosis, Forteo, could face generic competition from Indian drugmaker Sun Pharmaceuticals if the company can get a federal judge to declare that a Lilly patent won’t be infringed.
Purdue nabbed 175 U.S. patents for invention in 2020, among the most by a university worldwide
Indiana University ranked 53rd among universities for patents for invention last year, a jump in the rankings from previous years.
High court: Congress erred in patent dispute board setup
The case involved more than 200 administrative patent judges who make up the Patent Trial and Appeal Board and issue hundreds of decisions every year. The case is of particular importance to patent holders and inventors, including major technology companies.
Inventing opportunity: Patent filings rise to record during pandemic year
Indiana intellectual property attorneys had first-hand experience with the increase of patent filings during the pandemic, as researchers and inventors harnessed their creative skills while quarantining.
University professors rev up efforts to commercialize research, launch startups
More and more of the work done by university researchers is being spun off into companies and commercial applications that they or the universities own or are a part of.
Carmel spine surgeon wins $112M verdict in royalty battle with Medtronic
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
British Supreme Court rules in Eli Lilly’s favor in drug dispute
Britain's Supreme Court has ruled in favor of Eli Lilly and Co. in a patent dispute with generic drugmaker Actavis over Lilly's Alimta cancer treatment.
PELLEGRINO: Flawed system leaves innovators without fair patent protection
Patent owners have seen massive erosion of their rights coupled with a rise in basic enforcement costs and risks.
Carmel-based company wins patent case at U.S. Supreme Court
The justices ruled unanimously Monday that patent infringement lawsuits can be filed only in states where defendants are incorporated. The case was sparked by an appeal from Carmel-based TC Heartland LLC.
Supreme Court weighs possible curb on patent suit locations
The justices Monday heard arguments in a case involving Carmel-based flavoring maker TC Heartland that could end the reign of the Eastern District of Texas, which handles more than a third of all patent suits in the United States.
High court sides with Samsung in patent dispute with Apple
A unanimous Supreme Court on Tuesday sided with smartphone maker Samsung in its high-profile patent dispute with Apple over the design of the iPhone.
IU Research and Technology Corp. moves from canal to campus
A center that helps Indiana University researchers commercialize their discoveries has moved its operations to be closer to faculty, industry and research partners.
Interactive files federal patent suit against competitor
Indianapolis-based Interactive Intelligence Inc. has filed a federal patent lawsuit against Avaya Inc., a competitor with which Interactive Intelligence also had a long-standing patent license agreement.
Deal puts IU doctor’s research on path to market
A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
Zimmer patent lawsuit heads to U.S. Supreme Court
A subsidiary of Zimmer Biomet Inc. in Warsaw will argue that it should not have to pay about $248 million in a patent infringement case.
Lilly wins patent ruling over blockbuster drug Alimta
Eli Lilly and Co. won a court ruling that will keep generic versions of the chemotherapy drug Alimta off the U.S. market until a patent expires in 2022.